Evidence map›Paper›PMID 33711270›Full record

ArticleCell host & microbe2021

TGFβ restricts expansion, survival, and function of T cells within the tuberculous granuloma.

Benjamin H Gern, Kristin N Adams, Courtney R Plumlee, Caleb R Stoltzfus, Laila Shehata, Albanus O Moguche, Kathleen Busman-Sahay, Scott G Hansen, Michael K Axthelm, Louis J Picker and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 3 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Delayed-Type Hypersensitivity toInternational journal of molecular sciences · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Human memory CD4bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Benjamin H GernCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Kristin N AdamsCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Courtney R PlumleeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Caleb R StoltzfusDepartment of Immunology, University of Washington, Seattle, WA 98109, USA.
Laila ShehataDepartment of Immunology, University of Washington, Seattle, WA 98109, USA.
Albanus O MogucheDepartment of Immunology, University of Washington, Seattle, WA 98109, USA.
Kathleen Busman-SahayVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Scott G HansenVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Michael K AxthelmVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Louis J PickerVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Jacob D EstesVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Kevin B UrdahlCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA. Electronic address: kevin.urdahl@seattlechildrens.org.
Michael Y GernerDepartment of Immunology, University of Washington, Seattle, WA 98109, USA. Electronic address: gernermy@uw.edu.
University of Washington · USInfectious Disease Research Institute · USOregon Health & Science University · USChildren's Cancer Therapy Development Institute · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
Technology CoreU19AI135976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADEREM, ALAN A · 2018 to 2022
$17.0M
ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
T regulatory cells and immunity in tuberculosisR01AI076327 · NIAID · UNIVERSITY OF WASHINGTON · PI URDAHL, KEVIN B · 2009 to 2018
$4.5M
The Roles of Lymphoid Tissue Microenvironments in Guiding the Immune ResponseR01AI134713 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gerner · 2018 to 2026
$4.4M
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settingsR01AI134246 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI LINDENSTRØM, THOMAS, URDAHL, KEVIN B · 2017 to 2021
$3.3M
Novel approaches to study the intersection of cellular heterogeneity and tissue microanatomyR21AI142667 · NIAID · UNIVERSITY OF WASHINGTON · PI GERNER, MICHAEL · 2019 to 2020
$485k
NIAID NIH HHS 75N93019C00070NIAID NIH HHS R01 AI076327NIAID NIH HHS R01 AI134246NIAID NIH HHS R01 AI134713NIAID NIH HHS R21 AI142667NIAID NIH HHS U19 AI135976NICHD NIH HHS T32 HD007233NIH HHS P51 OD011092
6 · The paper itself

Abstract

CD4 T cell effector function is required for optimal containment of Mycobacterium tuberculosis (Mtb) infection. IFNɣ produced by CD4 T cells is a key cytokine that contributes to protection. However, lung-infiltrating CD4 T cells have a limited ability to produce IFNɣ, and IFNɣ plays a lesser protective role within the lung than at sites of Mtb dissemination. In a murine infection model, we observed that IFNɣ production by Mtb-specific CD4 T cells is rapidly extinguished within the granuloma but not within unaffected lung regions, suggesting localized immunosuppression. We identified a signature of TGFβ signaling within granuloma-infiltrating T cells in both mice and rhesus macaques. Selective blockade of TGFβ signaling in T cells resulted in an accumulation of terminally differentiated effector CD4 T cells, improved IFNɣ production within granulomas, and reduced bacterial burdens. These findings uncover a spatially localized immunosuppressive mechanism associated with Mtb infection and provide potential targets for host-directed therapy.

Indexed as

Adaptive ImmunityAnimalsCD4-Positive T-LymphocytesCell DeathCytokinesDisease Models, AnimalFemaleGranulomaInflammationInterferon-gammaLungMacaca mulattaMaleMiceMice, Inbred C57BLMice, KnockoutCytokinesInterferon-gammaTransforming Growth Factor betaadaptive immunitygranulomaIFNɣimmune cell traffickingimmune suppressionlung inflammationMycobacterium tuberculosisquantitative imagingT cell functionTGFβ

Identifiers

PMID33711270
PMCPMC8624870
OpenAlexW3135506379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.